» Authors » Zeru Peterson

Zeru Peterson

Explore the profile of Zeru Peterson including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 13
Citations 28
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Rodriguez S, Sharma S, Tiarks G, Peterson Z, Jackson K, Thedens D, et al.
Sci Rep . 2024 Jun; 14(1):13507. PMID: 38867062
Traumatic Brain Injury (TBI) induces neuroinflammatory response that can initiate epileptogenesis, which develops into epilepsy. Recently, we identified anti-convulsive effects of naltrexone, a mu-opioid receptor (MOR) antagonist, used to treat...
2.
Sharkey R, Bacon C, Peterson Z, Rootes-Murdy K, Salvador R, Pomarol-Clotet E, et al.
Mol Psychiatry . 2024 Apr; 29(10):3086-3096. PMID: 38671214
Formal thought disorder (FTD) is a clinical key factor in schizophrenia, but the neurobiological underpinnings remain unclear. In particular, the relationship between FTD symptom dimensions and patterns of regional brain...
3.
Kim J, Vanrobaeys Y, Kelvington B, Peterson Z, Baldwin E, Gaine M, et al.
Mol Psychiatry . 2024 Jan; 29(5):1310-1321. PMID: 38278994
Neurodevelopmental disorders (NDDs) are polygenic in nature and copy number variants (CNVs) are ideal candidates to study the nature of this polygenic risk. The disruption of striatal circuits is considered...
4.
Nickl-Jockschat T, Sharkey R, Bacon C, Peterson Z, Rootes-Murdy K, Salvador R, et al.
Res Sq . 2023 Oct; PMID: 37841855
Formal thought disorder (FTD) is a key clinical factor in schizophrenia, but the neurobiological underpinnings remain unclear. In particular, relationship between FTD symptom dimensions and patterns of regional brain volume...
5.
Wang R, Peterson Z, Balasubramanian N, Khan K, Chimenti M, Thedens D, et al.
bioRxiv . 2023 Aug; PMID: 37609170
Schizophrenia is marked by poor social functioning that can have a severe impact on quality of life and independence, but the underlying neural circuity is not well understood. Here we...
6.
Todd B, Luo Z, Gilkes N, Chimenti M, Peterson Z, Mix M, et al.
Acta Neuropathol Commun . 2023 Aug; 11(1):134. PMID: 37596685
Accumulating evidence suggests that type I interferon (IFN-I) signaling is a key contributor to immune cell-mediated neuropathology in neurodegenerative diseases. Recently, we demonstrated a robust upregulation of type I interferon-stimulated...
7.
Todd B, Luo Z, Gilkes N, Chimenti M, Peterson Z, Mix M, et al.
bioRxiv . 2023 Jun; PMID: 37333385
Accumulating evidence suggests that type I interferon (IFN-I) signaling is a key contributor to immune cell-mediated neuropathology in neurodegenerative diseases. Recently, we demonstrated a robust upregulation of type I interferon-stimulated...
8.
Sharkey R, Bacon C, Peterson Z, Rootes-Murdy K, Salvador R, Pomarol-Clotet E, et al.
medRxiv . 2023 Jun; PMID: 37333179
Formal thought disorder (FTD) is a key clinical factor in schizophrenia, but the neurobiological underpinnings remain unclear. In particular, relationship between FTD symptom dimensions and patterns of regional brain volume...
9.
Zeighami Y, Bakken T, Nickl-Jockschat T, Peterson Z, Jegga A, Miller J, et al.
PLoS Biol . 2023 Apr; 21(4):e3002058. PMID: 37079537
Genes associated with risk for brain disease exhibit characteristic expression patterns that reflect both anatomical and cell type relationships. Brain-wide transcriptomic patterns of disease risk genes provide a molecular-based signature,...
10.
Abel T, Kim J, Vanrobaeys Y, Peterson Z, Kelvington B, Gaine M, et al.
Res Sq . 2023 Feb; PMID: 36824977
Neurodevelopmental disorders (NDDs) are polygenic in nature and copy number variants (CNVs) are ideal candidates to study the nature of this polygenic risk. The disruption of striatal circuits is considered...